CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...
Explore how oncology data season is drawing attention to Nuvation Bio, Arcus Biosciences, and smaller cancer-focused biotech ...
The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points. The index has gained 4.36% over the past five days, adding 148.50 points as small-cap investor ...
In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...
The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,562.70, down 1.18% or 42.60 points yesterday. Despite the daily ...
The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,390.60, down 6.60 points or 0.19% in the latest session. The index has fallen 2.10% over the past five trading days, reflecting ongoing ...
After more than a decade of underperformance, small-cap stocks are quietly staging a comeback. Nathan Moser, co-portfolio manager for the Impax US Small Cap Strategy, believes the current rally is ...